Sepsis modulates aortic AT1 and P₂Y₆ receptors to produce vascular hyporeactivity in mice

References

• Finfer S, Bellomo R, Lipman J, et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Crit Care Med. 2004;30:589–596.
   Google Scholar
• Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–353.
   PubMed Web of Science ®Google Scholar
• Adhikari NKJ, Fowler RA, Bhagwanjee S, et al. Critical care and the global burden of critical illness in adults. Lancet. 2010;376(9749):1339–1346.
   PubMed Web of Science ®Google Scholar
• Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40(4):463–475.
   PubMed Web of Science ®Google Scholar
• Lyle NH, Pena OM, Boyd JH, et al. Barriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies. Ann N Y Acad Sci. 2014;1323:101–114.
   PubMed Web of Science ®Google Scholar
• Terblanche M, Almog Y, Rosenson RS, et al. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007;7(5):358–368.
   PubMed Web of Science ®Google Scholar
• Dunser MW, Ruokonen E, Pettila V, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13(6):R181.
   PubMed Web of Science ®Google Scholar
• De Backer SD, Aldecoa C, Njimi H, et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med. 2012;40(3):725–730.
   PubMed Web of Science ®Google Scholar
• Thomas VL, Nielsen MS. Administration of angiotensin II in refractory septic shock. Crit Care Med. 1991;19(8):1084–1086.
   PubMed Web of Science ®Google Scholar
• Yunge M, Petros A. Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child. 2000;82(5):388–389.
   PubMed Web of Science ®Google Scholar
• Wan L, Langenberg C, Bellomo R, et al. Angiotensin II in experimental hyperdynamic sepsis. Crit Care. 2009;13(6):R190.
   PubMed Web of Science ®Google Scholar
• Correa TD, Jeger V, Pereira AJ, et al. Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis. Crit Care Med. 2014;42(8):e550-59–e559.
   Web of Science ®Google Scholar
• Bucher M, Hobbhahn J, Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med. 2001;29(9):1750–1775.
   PubMed Web of Science ®Google Scholar
• Bucher M, Ittner KP, Hobbhahn J, et al. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension. 2001;38(2):177–182.
   PubMed Web of Science ®Google Scholar
• Corrêa TD, Takala J, Jakob SM. Angiotensin II in septic shock an update. Nurs Crit Care. 2018;13:30–37.
   Google Scholar
• Idzko M, Hammad H, van Nimwegen M, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med. 2007;13(8):913–919.
   PubMed Web of Science ®Google Scholar
• Jacobson KA, Boeynaems JM. P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today. 2010;15(13-14):570–578.
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic signaling. Br J Pharmacol. 2006;147(S1):S172–S181.
   PubMedGoogle Scholar
• Burnstock G, Dale N. Purinergic signalling during development and ageing. Purinergic Signal. 2015;11(3):277–305.
   PubMed Web of Science ®Google Scholar
• Erlinge D, Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 2008;4(1):1–20.
   PubMed Web of Science ®Google Scholar
• Warny M, Aboudola S, Robson SC, et al. P2Y6 nucleotide receptor mediates monocyte IL-8 production in response to UDP or lipopolysaccharide. J Biol Chem. 2001;276(28):26051–26056.
   PubMed Web of Science ®Google Scholar
• Grbic DM, Degagné E, Langlois C, et al. Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP. J Immunol. 2008;180(4):2659–2668.
   PubMed Web of Science ®Google Scholar
• Riegel AK, Faigle M, Zug S, et al. Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood. 2011;117(8):2548–2555.
   PubMed Web of Science ®Google Scholar
• Cox MA, Gomes B, Palmer K, et al. The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem Biophys Res Commun. 2005;330(2):467–473.
   PubMed Web of Science ®Google Scholar
• Bar I, Guns PJ, Metallo J, et al. Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol. 2008;74(3):777–784.
   PubMed Web of Science ®Google Scholar
• Kauffenstein G, Tamareille S, Prunier F, et al. Central role of P2Y6 UDP receptor in arteriolar myogenic tone. Arterioscler Thromb Vasc Biol. 2016;36(8):1598–1606.
   PubMed Web of Science ®Google Scholar
• Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock – a review of laboratory models and a proposal. J Surg Res. 1980;29(2):189–201.
   PubMed Web of Science ®Google Scholar
• Mishra SK, Choudhury S. Experimental protocol for cecal ligation and puncture model of polymicrobial sepsis and assessment of vascular functions in mice. Methods Mol Biol. 2018;1717:161–187.
   PubMedGoogle Scholar
• Li T, Yu B, Liu Z, et al. Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury. Nat Commun. 2018;9(1):11.
   PubMedGoogle Scholar
• Choudhury S, Kannan K, Pule Addison M, et al. Combined treatment with atorvastatin and imipenem improves survival and vascular functions in mouse model of sepsis. Vascul Pharmacol. 2015;71:139–150.
   PubMed Web of Science ®Google Scholar
• Singh P, Sharma P, Nakade UP, et al. Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis. Pharmacol Rep. 2018;70(6):1150–1157.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
   PubMed Web of Science ®Google Scholar
• Kandasamy K, Prawez S, Choudhury S, et al. Atorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α1-adrenoceptor mRNA expression. Shock. 2011;36(1):76–82.
   PubMed Web of Science ®Google Scholar
• Kimmoun A, Ducrocq N, Levy B. Mechanisms of vascular hyporesponsiveness in septic shock. Curr Vasc Pharmacol. 2013;11:139–149.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Dirksen WP, Babu GJ, et al. Differential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels. Am J Physiol Heart Circ Physiol. 2003;285(6):H2797–803.
   PubMed Web of Science ®Google Scholar
• Patzak A, Lai EY, Mrowka R, et al. AT1 receptors mediate angiotensin II–induced release of nitric oxide in afferent arterioles. Kidney Int. 2004;66(5):1949–1958.
   PubMed Web of Science ®Google Scholar
• Cervenka L, Mitchell KD, Oliverio MI, et al. Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions. Kidney Int. 1999;56(5):1855–1862.
   PubMed Web of Science ®Google Scholar
• Oliverio MI, Best CF, Smithies O, et al. Regulation of sodium balance and blood pressure by the at (1A) receptor for angiotensin II. Hypertension. 2000;35(2):550–554.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wei SG, Zhang ZH, et al. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension. 2008;51(3):727–733.
   PubMed Web of Science ®Google Scholar
• Boyle WA, Parvathaneni LS, Bourlier V, et al. iNOS gene expression modulates microvascular responsiveness in endotoxin challenged mice. Circ Res. 2000;87(7):E18–24.
   PubMed Web of Science ®Google Scholar
• Chen SJ, Li SY, Shih CC, et al. Nitric oxide contributes to abnormal vascular calcium regulation and reactivity induced by peritonitis-associated septic shock in rats. Shock. 2010;33(5):473–478.
   PubMed Web of Science ®Google Scholar
• Cahill PA, Redmond EM, Foster C, et al. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. Eur J Pharmacol. 1995;288(2):219–229.
   PubMed Web of Science ®Google Scholar
• Ichiki T, Usui M, Kato M, et al. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension. 1998;31(1 Pt 2):342–348.
   PubMed Web of Science ®Google Scholar
• Sasamura H, Nakazato Y, Hayashida T, et al. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 1997;30(1 Pt 1):35–41.
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic signaling in the cardiovascular cystem. Circ Res. 2017;120(1):207–228.
   PubMed Web of Science ®Google Scholar
• Yang Y, Duan W, Zhou J, et al. Protective effects of adenosine on the diabetic myocardium against ischemia-reperfusion injury: role of calpain. Med Hypotheses. 2012;79(4):462–464.
   PubMed Web of Science ®Google Scholar
• Govindan S, Taylor CW. P2Y receptor subtypes evoke different Ca2+ signals in cultured aortic smooth muscle cells. Purinergic Signal. 2012;8(4):763–777.
   PubMed Web of Science ®Google Scholar
• Ernst OP, Gramse V, Kolbe M, et al. Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc Natl Acad Sci U S A. 2007;104(26):10859–10864.
   PubMed Web of Science ®Google Scholar
• AbdAlla S, Lother H, Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 2000;407(6800):94–98.
   PubMed Web of Science ®Google Scholar
• Rozenfeld R, Gupta A, Gagnidze K, et al. AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. Embo J. 2011;30(12):2350–2363.
   PubMed Web of Science ®Google Scholar
• González-Hernández Mde L, Godínez-Hernández D, Bobadilla-Lugo RA, et al. Angiotensin-II type 1 receptor (AT1R) and alpha-1D adrenoceptor form a heterodimer during pregnancy-induced hypertension. Auton Autacoid Pharmacol. 2010;30(3):167–172.
   PubMedGoogle Scholar
• Rukavina Mikusic NL, Silva MG, Pineda AM, et al. Angiotensin receptors heterodimerization and trafficking: how much do they influence their biological function? Front Pharmacol. 2020;11:1179.
   PubMed Web of Science ®Google Scholar
• Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep. 2004;5(1):30–34.
   PubMed Web of Science ®Google Scholar
• Nishimura A, Sunggip C, Tozaki-Saitoh H, et al. Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension. Sci Signal. 2016;9(411):ra7.
   PubMed Web of Science ®Google Scholar
• Filizola M, Weinstein H. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics. Febs J. 2005;272(12):2926–2938.
   PubMed Web of Science ®Google Scholar
• Szalai B, Barkai L, Turu G, et al. Allosteric interactions within the AT1 angiotensin receptor homodimer: role of the conserved DRY motif. Biochem Pharmacol. 2012;84(4):477–485.
   PubMed Web of Science ®Google Scholar